Hims & Hers, Zealand, and Roche fall: Why weight loss drug stocks are down today
Several weight loss drug stocks are sliding today as pharmaceutical companies battle for dominance in the booming GLP-1 market —
Several weight loss drug stocks are sliding today as pharmaceutical companies battle for dominance in the booming GLP-1 market —
A group that represents pharmacies that have been producing off-brand versions of GLP-1 weight-loss drugs just filed another lawsuit against
Sales of Eli Lilly’s (LLY) blockbuster weight-loss drug Zepbound doubled in the fourth quarter year over year, despite missing the
Sales of Eli Lilly’s (LLY) blockbuster weight-loss drug Zepbound surged in the fourth quarter, despite missing the company’s initial sales
The cost of prescription drugs is set to climb in 2025 and beyond, according to TD Cowen’s 30th Annual Drug
Belgium is banning the sale of disposable electronic cigarettes starting Jan. 1, becoming the first European Union country to do
Healthcare professionals in the U.S. have noticed a significant increase in vaccine hesitancy among their patients, according to a survey
A pet food company has issued a recall following the death of a cat in Oregon from the bird flu,
Eli Lilly (LLY) announced today that its blockbuster weight-loss drug Zepbound was approved by the U.S. Food and Drug Administration
Nestle, the world’s largest producer of packaged food, just rolled out a new protein shot drink that it says will
No posts found.